Stryker launches national direct-to-patient marketing campaign

Go back to Stryker launches national direct-to-patient marketing campaign

Stryker (SYK) PT Raised to $310 at Oppenheimer

August 4, 2023 8:34 AM EDT

Oppenheimer analyst Steven Lichtman raised the price target on Stryker (NYSE: SYK) to $310.00 (from $305.00) while maintaining a Outperform rating following earnings.

The analyst commented, "SYK's 2Q23 sales of $4.996B (+11.9% organic) beat our/Street's ~$4.843B/$4.826BE. Outperformance was broad-based with particular standouts being Hips,... More